Reducing high risk of cardiovascular events in Type 2 diabetes mellitus: DIALOG Study results
Aim. To study the real-world pharmaceutical reduction of high cardiovascular disease (CVD) risk in patients with Type 2 diabetes mellitus (DM-2).Material and methods. In total, 200 DM-2 patients agreed to participate in the study, including survey, anthropometry, and laboratory tests.Results. In two...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1648 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|